“Comparative Study of Olopatadine Hydrochloride 0.1% and Emedastine Difumarate 0.05% Comparing Their Clinical Efficacy and Adverse Effects in Allergic Conjunctivitis”. Medical Forum Monthly 26, no. 5 (May 2, 2024). Accessed November 17, 2025. https://medicalforummonthly.com/index.php/mfm/article/view/2774.